19-June-2019: The global mammalian polyclonal IgG antibody market
size is expected to reach USD 1.21 billion by 2025 expanding at a CAGR of 5.1%,
according to a new report by Grand View Research, Inc. Advantages over other
forms of antibodies, increasing global R&D investments, and rising adoption
of novel diagnostic procedures are factors driving the market. Global rise in
chronic and infectious diseases also play a key role in propelling the market
growth.
Polyclonal antibodies are the
most preferred choice in routine laboratory tests, such as ELISA, microarray
assays, western blotting, flow cytometry, and immunohistochemistry. Production
of these does not require skilled professionals and large batches can be
produced as per client requirements. A polyclonal antibody can recognize
multiple antigens on one epitope and therefore can be utilized in the study of
various diseases ranging from cancer to metabolic diseases. Denatured proteins
are often detected with the use of polyclonal antibodies.
Thus, increasing use of these
products in the treatment of several chronic diseases is also anticipated to
fuel growth in the near future. Rising investments by major pharma companies,
such as Novartis and Roche, for the development of therapeutic antibodies and
novel diagnostic techniques and for QC purposes are also driving the market
growth. For instance, R&D investments by top 10 biotech companies increased
from USD 8.2 billion in 2010 to USD 10.2 billion in 2016, accounting for a 13%
increase.
In
depth research report on Mammalian Polyclonal IgG Antibody Market
Further
key findings from the study suggest:
· Large
amount of polysera obtained from goats and predominant use of these animals as
hosts has contributed to its large market share in 2017
· Metabolic
biomarkers are expected to hold the largest market share during the forecast
period due to growing prevalence of chronic diseases, such as cardiovascular
diseases (CVDs) and cancer
· ELISA
tests provide accurate diagnosis of disease, such as AIDS, Lyme disease,
syphilis, pernicious anemia, Rocky Mountain spotted fever, squamous cell
carcinoma, chickenpox, shingles, and other bacterial and viral infections, than
other antibody-based assays contributing to its high market share
· Availability
of technologically advanced equipment and presence of major market players has
attributed to the North American region garnering large market share
· Asia
Pacific is anticipated to gain significant market share in near future due to
rising R&D investment and presence of target population
· Few key
companies in the global mammalian polyclonal IgG antibody market include Abcam
PLC; Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific; Merck KgaA; Cell
Signaling Technologies, Inc.; and Hoffmann-La Roche Ltd.
Grand View Research has
segmented the global mammalian polyclonal IgG antibody market on the basis of
type, product, application, end use, and region:
Mammalian
Polyclonal IgG Antibody Type Outlook (Revenue, USD Million, 2014 - 2025)
· Goat
· Rabbit
· Horse
· Mouse
· Others
Mammalian
Polyclonal IgG Antibody Product Outlook (Revenue, USD Million, 2014 - 2025)
· Cardiac
Markers
· Metabolic
Markers
· Renal
Markers
· Others
Mammalian
Polyclonal IgG Antibody Application Outlook (Revenue, USD Million, 2014 - 2025)
· ELISA
· Immunoturbidometry
· Immunoelectrophoresis
· Antibody
Identification
· Immunohistochemistry
· Immunocytochemistry
· Western
Blotting
Mammalian
Polyclonal IgG Antibody End Use Outlook (Revenue, USD Million, 2014 - 2025)
· Hospitals
· Diagnostic
Centers
· Academic
and Research Centers
Browse
more research reports of this category:
About
Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
No comments:
Post a Comment